close

3 Reasons to Avoid ACT and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

ACT Cover Image

Enact Holdings has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 17.3% to $47.26 per share while the index has gained 16.9%.

Is there a buying opportunity in Enact Holdings, or does it present a risk to your portfolio? Get the full stock story straight from our expert analysts, it’s free.

Why Do We Think Enact Holdings Will Underperform?

We don’t have much confidence in Enact Holdings. Here are three reasons why ACT doesn’t excite us, plus one stock we’d rather own.

1. Net Premiums Earned Hit a Plateau

When insurers sell policies, they protect themselves from extremely large losses or an outsized accumulation of losses with reinsurance (insurance for insurance companies). Net premiums earned are therefore gross premiums less what’s ceded to reinsurers as a risk mitigation and transfer strategy.

Enact Holdings’s net premiums earned was flat over the last five years, much worse than the broader insurance industry. This shows that policy underwriting underperformed its other business lines.

Enact Holdings Trailing 12-Month Net Premiums Earned

2. Projected Revenue Growth Shows Limited Upside

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Enact Holdings’s revenue to stall, a slight deceleration versus its 2.7% annualized growth for the past two years. This projection doesn’t excite us and implies its products and services will face some demand challenges.

3. EPS Barely Growing

Analyzing the long-term change in earnings per share (EPS) shows whether a company’s incremental sales were profitable — for example, revenue could be inflated through excessive spending on advertising and promotions.

Enact Holdings’s full-year EPS grew at a weak 4.4% compounded annual growth rate over the last four years, worse than the broader insurance sector.

Enact Holdings Trailing 12-Month EPS (Non-GAAP)

Final Judgment

Enact Holdings falls short of our quality standards. That said, the stock currently trades at 1.2× forward P/B (or $47.26 per share). While this valuation is reasonable, we don’t see a big opportunity at the moment. There are superior stocks to buy right now. We’d suggest looking at an all-weather company that owns household favorite Taco Bell.

Stocks We Like More Than Enact Holdings

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  250.47
+1.09 (0.44%)
AAPL  339.71
+3.79 (1.13%)
AMD  632.04
+2.78 (0.44%)
BAC  56.60
+0.57 (1.03%)
GOOG  341.93
+2.92 (0.86%)
META  749.30
-28.29 (-3.64%)
MSFT  515.32
+17.39 (3.49%)
NVDA  225.55
+0.97 (0.43%)
ORCL  138.38
-1.16 (-0.83%)
TSLA  373.75
-4.19 (-1.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at /week.